Parathyroid hormone‐related protein regulates the growth of orthotopic human lung tumors in athymic mice

Parathyroid hormone‐related protein (PTHrP) has growth regulatory effects for many malignant cells and may influence the progression of carcinomas of the breast, prostate, and lung. In the current study, the authors investigated the in vivo and in vitro effects of PTHrP neutralizing antibody and PTHrP treatment on the growth of BEN cells, a human lung squamous cell carcinoma line that expresses PTHrP and its receptor.

[1]  K. Ichizuka,et al.  The role of parathyroid hormone-related protein in intra-tracheal fluid. , 2000, Endocrine journal.

[2]  S. Rabbani.  Molecular mechanism of action of parathyroid hormone related peptide in hypercalcemia of malignancy: therapeutic strategies (review). , 2000, International journal of oncology.

[3]  D. Summers-Torres,et al.  Direct Laryngoscopy in Mice. , 1999, Contemporary topics in laboratory animal science.

[4]  P. Ravdin.  Should HER2 status be routinely measured for all breast cancer patients? , 1999, Seminars in oncology.

[5]  W. Hiddemann,et al.  Monoclonal antibody therapy for B cell non-Hodgkin's lymphomas: emerging concepts of a tumour-targeted strategy. , 1999, European journal of cancer.

[6]  T. Martin,et al.  Importin β Recognizes Parathyroid Hormone-related Protein with High Affinity and Mediates Its Nuclear Import in the Absence of Importin α* , 1999, The Journal of Biological Chemistry.

[7]  S. Rabbani,et al.  Over‐production of parathyroid hormone–related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells In vivo , 1999, International journal of cancer.

[8]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[9]  D. Bruns,et al.  Expression and specific immunolocalization of the human parathyroid hormone/parathyroid hormone-related protein receptor in the uteroplacental unit. , 1998, American journal of obstetrics and gynecology.

[10]  K. Nagao,et al.  Establishment of two human small cell lung cancer cell lines: the evidence of accelerated production of parathyroid hormone-related protein with tumor progression. , 1998, Cancer letters.

[11]  A. F. Stewart,et al.  Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Guise.  Parathyroid hormone‐related protein and bone metastases , 1997, Cancer.

[13]  M. Chuang,et al.  Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population , 1997, Journal of endocrinological investigation.

[14]  Y. Miyagi,et al.  Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. , 1997, Cancer research.

[15]  L. Deftos,et al.  Parathyroid hormone-related protein, an autocrine growth inhibitor of alveolar type II cells. , 1997, The American journal of physiology.

[16]  M. Birch,et al.  Clonal heterogeneity of the growth and invasive response of a human breast carcinoma cell line to parathyroid hormone-related peptide fragments. , 1997, Carcinogenesis.

[17]  Y. Ichinose,et al.  Tumor‐induced hypercalcemia and parathyroid hormone‐related protein in lung carcinoma , 1996, Cancer.

[18]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[19]  Yukiko Ozawa,et al.  An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. , 1996, Cancer research.

[20]  L. Deftos,et al.  Parathyroid hormone-related protein, an autocrine regulatory factor in alveolar epithelial cells. , 1996, The American journal of physiology.

[21]  B. Lanske,et al.  Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death , 1995, Molecular and cellular biology.

[22]  M. Birch,et al.  Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: evidence for growth-inhibiting and invasion-promoting effects , 1995, Molecular and Cellular Endocrinology.

[23]  W. Ratcliffe,et al.  Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. , 1995, Postgraduate medical journal.

[24]  L. Deftos,et al.  Alveolar epithelial cells express and secrete parathyroid hormone-related protein. , 1994, American journal of respiratory cell and molecular biology.

[25]  Guan Wu,et al.  Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. , 1994, Urology.

[26]  T. Schilling,et al.  Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. , 1994, The Journal of clinical endocrinology and metabolism.

[27]  J. Rhim,et al.  Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. , 1994, Molecular endocrinology.

[28]  W. Wachsman,et al.  Parathyroid hormone-like protein: alternative messenger RNA splicing pathways in human cancer cell lines. , 1994, Cancer research.

[29]  L. Deftos,et al.  Parathyroid hormone-like protein is a secretory product of atrial myocytes. , 1993, The Journal of clinical investigation.

[30]  P. Burton,et al.  Parathyroid hormone‐related peptide can regulate the growth of human lung cancer cells, and may form part of an autocrine TGF‐α loop , 1992 .

[31]  J. Rhim,et al.  Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. , 1992, The Journal of biological chemistry.

[32]  A. Gazdar,et al.  All major lung cancer cell types produce parathyroid hormone-like protein: heterogeneity assessed by high performance liquid chromatography. , 1991, Endocrinology.

[33]  M. Fukase,et al.  The activation of cAMP-dependent protein kinase is directly linked to the inhibition of osteoblast proliferation (UMR-106) by parathyroid hormone-related protein. , 1991, Biochemical and biophysical research communications.

[34]  R. Kitazawa,et al.  Immunohistologic evaluation of parathyroid hormone‐related protein in human lung cancer and normal tissue with newly developed monoclonal antibody , 1991, Cancer.

[35]  R. Warrell,et al.  Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. , 1990, The New England journal of medicine.

[36]  P. Burton,et al.  Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma. , 1990, Biochemical and biophysical research communications.

[37]  D. Banville,et al.  Parathyroid hormone-like peptide: Molecular characterization and biological properties , 1989, Trends in Endocrinology & Metabolism.

[38]  J. Orloff,et al.  Parathyroid hormone-related protein modulates the effect of transforming growth factor-beta on deoxyribonucleic acid and collagen synthesis in fetal rat bone cells. , 1989, Endocrinology.

[39]  B. Kemp,et al.  Parathyroid hormone-related protein of malignancy: active synthetic fragments. , 1987, Science.

[40]  L. Suva,et al.  Parathyroid hormone-related protein purified from a human lung cancer cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Dowsett,et al.  Immunoreactive calcitonin production by human lung carcinoma cells in culture. , 1975, British Journal of Cancer.